A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis

Abstract: Multiple myeloma is, in most patients, an incurable cancer. Its precursors can be identified with routine tests setting the stage for early intervention to prevent active myeloma. We investigated the efficacy and safety of pembrolizumab, an antiprogrammed cell death 1 antibody, in smolderi...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Elisabet E. Manasanch, Guangchun Han, Rohit Mathur, Yun Qing, Zheng Zhang, Hans Lee, Donna M. Weber, Behrang Amini, Zuzana Berkova, Karina Eterovic, Shaojun Zhang, Jianhua Zhang, Xingzhi Song, Xizeng Mao, Margaret Morgan, Lei Feng, Veera Baladandayuthapani, Andrew Futreal, Linghua Wang, Sattva S. Neelapu, Robert Z. Orlowski
Format:	Artigo
Sprog:	Inglês
Udgivet:	Elsevier 2019-08-01
Serier:	Blood Advances
Online adgang:	http://www.sciencedirect.com/science/article/pii/S2473952920306364
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!